We are live on !
Find out more
Daniel Loeb Third Point
AUM
$4.68B
Turnover
50%
1-Year Est. Return
37.3%
Daniel Loeb is the founder of Third Point, an event-driven and activist-oriented hedge fund. He is known for pointed letters to management teams, catalyst-driven investing, and a flexible mandate across equities and credit. Loeb’s campaigns and portfolio shifts regularly generate attention beyond specialist hedge fund circles.
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.3%
3 Year Est. Return
+159.49%
5 Year Est. Return
+329.12%
10 Year Est. Return
+1,791.94%
AUM
$11.3B
AUM Growth
+$1.03B
(+10%)
Cap. Flow
+$318M
Cap. Flow % of AUM
Cap. Flow %
2.82%
Top 10 Holdings %
Top 10 Hldgs %
65.81%
Holding
46
New
8
Increased
10
Reduced
9
Closed
14
Avg Time Held
Equity + Options
1
year
Top 10 Avg Time Held
Equity + Options
1
year
Top 20 Avg Time Held
Equity + Options
1
year
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
1
year
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$618M |
| 2 |
Alibaba
BABA
|
+$556M |
| 3 |
NXP Semiconductors
NXPI
|
+$289M |
| 4 |
Vulcan Materials
VMC
|
+$201M |
| 5 |
FMC
FMC
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$329M |
| 2 |
Baxter International
BAX
|
+$284M |
| 3 |
Salesforce
CRM
|
+$247M |
| 4 |
Qualcomm
QCOM
|
+$201M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.82% |
| 2 | Communication Services | 17.07% |
| 3 | Materials | 14.37% |
| 4 | Financials | 11.7% |
| 5 | Consumer Discretionary | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Baxter International
BAX
$13.1B
| $2.48B | 22% |
41,000,000
-5,000,000
| -11% | -$284M |
2015 Q2
8 quarters
|
|
2
DuPont de Nemours
DD
$17.6B
| $1.01B | 8.94% |
6,318,098
+118,465
| +2% | +$18.8M |
2013 Q4
14 quarters
|
|
|
3
Blackrock
BLK
$176B
| $655M | 5.8% |
+1,550,000
| New | +$618M |
2017 Q2
0 quarters
|
|
|
4
Alibaba
BABA
$271B
| $634M | 5.62% |
+4,500,000
| New | +$556M |
2017 Q2
0 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$4.17T
| $535M | 4.74% |
11,500,000
+2,400,000
| +26% | +$112M |
2016 Q1
5 quarters
|
|
6
Meta Platforms (Facebook)
META
$1.81T
| $528M | 4.68% |
3,500,000
+500,000
| +17% | +$74.3M |
2016 Q2
4 quarters
|
|
7
Constellation Brands
STZ
$22.2B
| $484M | 4.29% |
2,500,000
-500,000
| -17% | -$89M |
2013 Q2
16 quarters
|
|
|
TWX
8
DELISTED
Time Warner Inc
TWX
| $377M | 3.34% |
3,750,000
+250,000
| +7% | +$24.8M |
2016 Q4
2 quarters
|
|
9
Bank of America
BAC
$358B
| $364M | 3.23% |
15,000,000
+1,500,000
| +11% | +$35M |
2016 Q4
2 quarters
|
|
|
BID
10
DELISTED
Sotheby's
BID
| $358M | 3.17% |
6,661,604
| – | – |
2013 Q2
16 quarters
|
|
11
T-Mobile US
TMUS
$171B
| $318M | 2.82% |
5,250,000
+250,000
| +5% | +$16.3M |
2017 Q1
1 quarter
|
|
|
12
NXP Semiconductors
NXPI
$57.8B
| $296M | 2.62% |
+2,700,000
| New | +$289M |
2017 Q2
0 quarters
|
|
13
Danaher
DHR
$161B
| $278M | 2.47% |
3,722,400
+225,600
| +6% | +$16.9M |
2015 Q3
7 quarters
|
|
14
Sherwin-Williams
SHW
$81.4B
| $263M | 2.33% |
2,250,000
-450,000
| -17% | -$50.3M |
2016 Q2
4 quarters
|
|
15
General Dynamics
GD
$93.1B
| $238M | 2.11% |
1,200,000
-50,000
| -4% | -$9.8M |
2016 Q2
4 quarters
|
|
16
Elevance Health
ELV
$92.9B
| $235M | 2.08% |
1,250,000
+100,000
| +9% | +$18M |
2016 Q4
2 quarters
|
|
17
S&P Global
SPGI
$127B
| $219M | 1.94% |
1,500,000
| – | – |
2016 Q2
4 quarters
|
|
18
Mohawk Industries
MHK
$8.15B
| $211M | 1.87% |
875,000
-75,000
| -8% | -$17.7M |
2014 Q4
10 quarters
|
|
|
19
Vulcan Materials
VMC
$33.4B
| $203M | 1.8% |
+1,600,000
| New | +$201M |
2017 Q2
0 quarters
|
|
20
Humana
HUM
$49.6B
| $180M | 1.6% |
750,000
-175,000
| -19% | -$39.6M |
2016 Q3
3 quarters
|
|
21
Honeywell
HON
$67B
| $170M | 1.51% |
1,411,421
-110,699
| -7% | -$13.1M |
2016 Q4
2 quarters
|
|
22
Charter Communications
CHTR
$12.6B
| $168M | 1.49% |
500,000
-300,000
| -38% | -$100M |
2016 Q2
4 quarters
|
|
23
Dell
DELL
$287B
| $153M | 1.35% |
8,908,095
| – | – |
2016 Q3
3 quarters
|
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
| $152M | 1.35% |
+1,250,000
| New | +$145M |
2017 Q2
0 quarters
|
|
|
25
FMC
FMC
$880M
| $146M | 1.29% |
+2,306,000
| New | +$148M |
2017 Q2
0 quarters
|
|
Similar funds
TCIM
Daniel Loeb's Q2 2017 Portfolio in Review
As of Q2 2017, Daniel Loeb held 46 positions worth $11.3B, up 10% from $10.2B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Daniel Loeb's Q2 2017 filing shows 8 new, 10 increased, 9 reduced and 14 closed positions. Its largest new stake was Blackrock: 1,550,000 shares worth $655M. The largest sale was JPMorgan Chase, an estimated $329M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Materials.
- Daniel Loeb's largest Q2 2017 buy was Blackrock: 1,550,000 shares worth $655M.
- Daniel Loeb added most to Alphabet (Google) Class A in Q2 2017, an estimated $112M increase.
- Daniel Loeb's biggest Q2 2017 reduction was Baxter International, cutting an estimated $284M.
- Daniel Loeb fully exited JPMorgan Chase in Q2 2017, selling an estimated $329M.
- Daniel Loeb's ten largest holdings make up 66% of its $11.3B portfolio in Q2 2017.
- Daniel Loeb opened 8 new positions and closed 14 in Q2 2017.
- Daniel Loeb's portfolio value rose 10% quarter-over-quarter to $11.3B.
Based on Third Point's 13F filing for Q2 2017, filed 11 Aug 2017.